Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
The authors report a significant increase in dyscontrol in patients with borderline personality disorder who were taking alprazolam during a double-blind, placebo-controlled crossover study. They suggest that caution be used in prescribing alprazolam to patients with similar histories.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on